Nasopharyngeal Diseases  >>  Inlyta (axitinib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Inlyta (axitinib) / Pfizer
NCT01249547: Nasopharyngeal Carcinoma (NPC) Axitinib

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Completed
2
37
RoW
axitinib
Chinese University of Hong Kong
Recurrent or Metastatic NPC
12/16
12/16

Download Options